Order Article Reprints

Vives J, Hernández J, Mirabel C, Puigdomenech-Poch M, Romeo-Guitart D, Marmolejo-Martínez-Artesero S, Cabrera-Pérez R, Jaramillo J, Kumru H, García-López J, et al. Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance. Cells. 2022; 11(14):2153. https://doi.org/10.3390/cells11142153

Vives, Joaquim, Joaquim Hernández, Clémentine Mirabel, Maria Puigdomenech-Poch, David Romeo-Guitart, Sara Marmolejo-Martínez-Artesero, Raquel Cabrera-Pérez, Jessica Jaramillo, Hatice Kumru, Joan García-López, and et al. 2022. "Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance" Cells 11, no. 14: 2153. https://doi.org/10.3390/cells11142153

Vives, J., Hernández, J., Mirabel, C., Puigdomenech-Poch, M., Romeo-Guitart, D., Marmolejo-Martínez-Artesero, S., Cabrera-Pérez, R., Jaramillo, J., Kumru, H., García-López, J., Vidal-Samsó, J., Navarro, X., & Coll-Bonet, R. (2022). Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance. Cells, 11(14), 2153. https://doi.org/10.3390/cells11142153